Brucellosis of the Spine (Spinal Brucellosis)

Spinal brucellosis is the most common form of osteoarticular brucellosis, a zoonotic infection caused by Brucella species. It represents one of the most important causes of spondylodiscitis in endemic regions.

Key clinical features distinguishing from TB:

• More indolent course with systemic symptoms
• Less severe destruction and deformity
• Paraspinal abscess less common and smaller
• Neurological involvement less severe
• Better response to medical treatment

Imaging Atlas

View larger

Treatment outcomes:

• Cure rate: 95% with appropriate antibiotics
• Relapse rate: 5-10% with adequate treatment (higher with monotherapy)
• Time to response: 2-4 weeks for symptom improvement
• Residual back pain: 20-30% have some long-term pain

Complications:

Prognostic factors:

• Early diagnosis improves outcomes
• Neurological involvement worsens prognosis
• Treatment delay associated with higher complication rate
• Compliance with prolonged antibiotics crucial

Global epidemiology:

Brucellosis is the commonest bacterial zoonosis worldwide, with the heaviest burden across the Mediterranean basin, Middle East, Central Asia, the Indian subcontinent, sub-Saharan Africa and Latin America. Incidence is highly heterogeneous: many high-income countries that have eradicated bovine brucellosis (much of Western Europe, North America, Japan, Australia and New Zealand) now see almost exclusively imported cases in travellers and migrants, whereas hyperendemic regions report population incidence orders of magnitude higher. There is no implant registry for spinal infection; the relevant "registries" are national notifiable-disease surveillance systems (e.g. national public-health agencies and WHO/FAO/OIE reporting), which capture confirmed human cases and inform regional risk.

Side-by-side guidance:

Diagnostic and biosafety considerations:

Brucella is a hazard-group/risk-group 3 organism; laboratories must be alerted to the clinical suspicion so that cultures are handled in appropriate containment and incubated for the extended period required. In non-endemic settings, local laboratories may have limited experience, and serology (Rose Bengal screening with confirmatory agglutination/ELISA) plus molecular testing through reference laboratories is the mainstay. A clear travel, dietary and occupational history is the single most important step that prompts the correct test.

High- vs limited-resource practice variation:

• High-resource settings: MRI is readily available for early diagnosis and monitoring; automated blood-culture systems and PCR improve and accelerate confirmation; infectious-diseases input guides prolonged therapy and surgery is reserved for neurological deficit, instability or abscess unresponsive to antibiotics.
• Limited-resource / hyperendemic settings: Diagnosis often rests on serology and plain radiographs (Pedro Pons sign), with MRI and PCR less accessible; the doxycycline + rifampicin oral regimen is favoured for outpatient feasibility and adherence despite a higher relapse risk than aminoglycoside-containing regimens; the major public-health lever is control of animal reservoirs and pasteurisation of dairy.

• Optimal regimen: Meta-analysis evidence (Skalsky, BMJ 2008) shows doxycycline-rifampicin relapses more than aminoglycoside-containing regimens, yet the all-oral doxycycline-rifampicin combination remains widely used for adherence in outpatient and limited-resource settings. The trade-off between efficacy and feasibility is unresolved for spinal disease specifically.
• Treatment duration: There is no randomised evidence defining the ideal duration for brucellar spondylitis. Practice ranges from a minimum of 3 months to 6 months or longer, individualised to clinical response, abscess and inflammatory-marker normalisation rather than a fixed endpoint.
• Role and timing of surgery: Thresholds for operating on epidural or paravertebral abscess without progressive neurology are debated; many collections resolve with antibiotics alone, but the size and response that should trigger drainage are not standardised.
• Monitoring cure and defining relapse: Serological titres can persist after microbiological cure, so distinguishing true relapse from residual antibody or non-infective mechanical back pain is difficult; the relative value of MRI, inflammatory markers and antibody assays for follow-up is not firmly established.
• Empirical therapy in dual-endemic regions: Where tuberculosis and brucellosis coexist, whether to await tissue/molecular confirmation or start empirical therapy when both are plausible remains a clinical judgement, given the very different drug regimens and durations.

The investigations cover the agglutination test and list 'negative serology despite clinical suspicion' as a reason to biopsy, but never explain why brucella serology can be falsely negative.

• The prozone phenomenon. With very high antibody titres, the standard agglutination test can be falsely negative at low dilutions because antibody excess prevents the antigen-antibody lattice needed for visible agglutination. The fix is to test further serial dilutions (well beyond 1:320) - agglutination then appears at the higher dilutions.
• Blocking (incomplete) antibodies. In chronic or relapsing disease, non-agglutinating IgG/IgA can give a negative agglutination test; the Coombs (anti-human-globulin) test detects them.
• Other causes. Very early acute infection (before antibodies rise) and B. canis (a rough-lipopolysaccharide species not detected by the standard smooth-antigen test) can also be seronegative - so a negative result with strong suspicion warrants dilutions, a Coombs test, and culture/PCR.

The topic states that 'brucellae lodge in vertebral metaphyseal vessels' and that the Pedro Pons sign is the earliest change, but never links the two.

• Where the organisms seed. Hematogenous brucellae reach the vertebra through the segmental / metaphyseal end-arteries, which arborise in the richly vascular anterosuperior endplate region - so seeded organisms lodge there first.
• Why the anterosuperior corner erodes first. That is exactly why the earliest radiographic change is erosion of the anterosuperior corner (the Pedro Pons sign), before disc-space narrowing.
• Why it then heals rather than collapses. Because the response is granulomatous and less destructive, the corner lesion tends to repair with reactive sclerosis and osteophyte ('parrot-beak') formation rather than the collapse and gibbus of tuberculosis.